SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-043417
Filing Date
2024-04-10
Accepted
2024-04-10 16:58:13
Documents
13
Period of Report
2024-04-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbp-20240409.htm   iXBRL 8-K 51254
2 EX-10.1 crbp-ex10_1.htm EX-10.1 213374
3 EX-10.2 crbp-ex10_2.htm EX-10.2 212571
  Complete submission text file 0000950170-24-043417.txt   650923

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20240409.xsd EX-101.SCH 25032
17 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20240409_htm.xml XML 4767
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 24836466
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)